TY - JOUR
T1 - Estrogen and progesterone receptors in ovarian epithelial tumors
AU - Lindgren, Peter R.
AU - Cajander, Stefan
AU - Bäckström, Torbjörn
AU - Gustafsson, Jan Åke
AU - Mäkelä, Sari
AU - Olofsson, Jan I.
N1 - Funding Information:
The authors wish to thank Ms. Inga-Lis Fransson for skillful technical assistance. This work was supported by grants from The Swedish Medical research Council #13144 (JIO), The Swedish Society of Medicine, The Research Foundation of the Department of Radiation Sciences/Oncology, Umeå University, Sweden.
PY - 2004/6/30
Y1 - 2004/6/30
N2 - Epidemiological studies have indicated a relationship between ovarian cancer and gonadal steroid hormones. In the present study immunohistochemical localization in combination with morphometry were used to characterize changes in the pattern of expression for estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and progesterone receptor (PR), in epithelial cells of normal ovaries, and in benign, borderline and malignant ovarian tumors of different types (n=53). Positive correlations with immunoreactivity of the cell proliferation-marker, Ki67, and the apoptosis-related marker of genetic instability, p53, between the different tumor types were also found. A simultaneous expression of ERα, ERβ and PR in epithelial cells of all histopathological tumor types was noted, with the notable exception of all mucinous tumors who remained ERβ-positive, but ERα- and PR-negative. Epithelial cells in ovarian cancer tissue showed significantly lower mean immunoreactivity of ERβ and PR, but not ERα, than in normal ovarian tissue. These novel findings may provide a rationale for the development of new diagnostic and possibly therapeutic strategies.
AB - Epidemiological studies have indicated a relationship between ovarian cancer and gonadal steroid hormones. In the present study immunohistochemical localization in combination with morphometry were used to characterize changes in the pattern of expression for estrogen receptor alpha (ERα), estrogen receptor beta (ERβ), and progesterone receptor (PR), in epithelial cells of normal ovaries, and in benign, borderline and malignant ovarian tumors of different types (n=53). Positive correlations with immunoreactivity of the cell proliferation-marker, Ki67, and the apoptosis-related marker of genetic instability, p53, between the different tumor types were also found. A simultaneous expression of ERα, ERβ and PR in epithelial cells of all histopathological tumor types was noted, with the notable exception of all mucinous tumors who remained ERβ-positive, but ERα- and PR-negative. Epithelial cells in ovarian cancer tissue showed significantly lower mean immunoreactivity of ERβ and PR, but not ERα, than in normal ovarian tissue. These novel findings may provide a rationale for the development of new diagnostic and possibly therapeutic strategies.
KW - Immunohistochemistry
KW - Ki67
KW - Ovarian cancer
KW - Ovarian tumors
KW - p53
KW - Steroid hormone receptors
UR - http://www.scopus.com/inward/record.url?scp=3042662331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042662331&partnerID=8YFLogxK
U2 - 10.1016/j.mce.2004.02.020
DO - 10.1016/j.mce.2004.02.020
M3 - Article
C2 - 15223136
AN - SCOPUS:3042662331
SN - 0303-7207
VL - 221
SP - 97
EP - 104
JO - Molecular and cellular endocrinology
JF - Molecular and cellular endocrinology
IS - 1-2
ER -